Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Current Research on HIV Drug Resistance
| Current Research on HIV Drug Resistance |
| Autore | Ji Hezhao |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (152 p.) |
| Soggetto topico |
Medicine
Epidemiology & medical statistics |
| Soggetto non controllato |
HIV drug resistance
sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3'-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance |
| ISBN | 3-0365-5512-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910637793603321 |
Ji Hezhao
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
| Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development |
| Autore | Drašar Pavel B |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (334 p.) |
| Soggetto topico |
Industrial chemistry and chemical engineering
Technology: general issues |
| Soggetto non controllato |
alkaloids
amide bond anabolic anti-HIV activity antimicrobial activity antiviral therapy artemisinin betulinic acid bevirimat bioavailability BODIPY cancer cancer cells cannabichromene cannabidiol (CBD) cannabinoid receptors (CB1 and CB2) cannabinoids Cannabis sativa (Cannabis) capsaicinoids cardiometabolic diseases cell-cycle chloroquine COVID-19 curcumin curcumin analogues curcumin delivery systems curcumin derivatives cytotoxicity diabetes Duchenne muscular dystrophy ecdysteroid ecdysterone EGFR endocannabinoidome fluorescent microscopy food intake Huisgen 1,3-dipolar cycloaddition inflammation ivermectin lignans lipid accumulation lipidomics lipogenesis lung cancer LXRα MAFLD malaria Mas1 maturation inhibitor membrane fusion metabolism microbiota MMP2 molecular ribbon moxidectin multifunctional PEG3 derivative n/a natural product natural product synthesis natural remedy NF-κB inhibition NSCLC obesity onchocerciasis osteoporosis overweight Papaver somniferum (opium poppy) PD-L1 phytocannabinoids phytochemical quinine respiratory diseases sarcopenia SARS-CoV-2 secondary metabolites STAT3 supramolecular self-assembly tanshinone IIA tetrahydrocannabinol (THC) thermos-TRPs triterpenoid TRPA1 tumorsphere United States Food and Drug Administration-approved drug ursolic acid vinblastine vincristine viral fusion inhibitor α,α-dimethylheptyl effect β-ecdysone |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580203103321 |
|
Drašar Pavel B
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||